NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.56
-0.36 (-4.04%)
Mar 10, 2026, 4:00 PM EDT - Market closed
NeoGenomics Stock Forecast
Stock Price Forecast
The 7 analysts that cover NeoGenomics stock have a consensus rating of "Buy" and an average price target of $11.14, which forecasts a 30.14% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $15.
Price Target: $11.14 (+30.14%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +51.87% | Feb 24, 2026 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +75.23% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +63.55% | Jan 12, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +40.19% | Sep 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6.5 → $11 | Buy | Maintains | $6.5 → $11 | +28.50% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
804.64M
from 727.33M
Increased by 10.63%
Revenue Next Year
882.96M
from 804.64M
Increased by 9.73%
EPS This Year
0.17
from -0.84
EPS Next Year
0.32
from 0.17
Increased by 90.03%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 838.0M | 929.3M | |||
| Avg | 804.6M | 883.0M | |||
| Low | 778.2M | 843.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.2% | 15.5% | |||
| Avg | 10.6% | 9.7% | |||
| Low | 7.0% | 4.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.20 | 0.43 | |||
| Avg | 0.17 | 0.32 | |||
| Low | 0.13 | 0.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 158.9% | |||
| Avg | - | 90.0% | |||
| Low | - | 11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.